Beryl Drugs website temporarily unavailable due to technical issue

0 min read     Updated on 21 Jul 2026, 01:18 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Beryl Drugs Limited reported on July 20, 2026, that its website is temporarily unavailable due to an unexpected technical issue. The company confirmed that business operations and financial systems remain unaffected and that restoration activities are underway. The disclosure was made pursuant to Regulation 30 of the SEBI LODR Regulations, 2015.

powered bylight_fuzz_icon
46165672

*this image is generated using AI for illustrative purposes only.

Beryl Drugs Limited reported on July 20, 2026, that its official website is temporarily unavailable due to an unexpected technical issue. The company confirmed that the disruption is limited to website accessibility and has not impacted its business operations, financial systems, or statutory records.

Upon identifying the problem, Beryl Drugs immediately began coordinating with technical service providers to implement corrective measures. Restoration activities are currently in progress as the company works to resume normal website operations at the earliest.

The intimation was submitted to the BSE in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the applicable provisions of the Companies Act, 2013. The disclosure was signed by Sudhir Sethi, Chairman & Director.

Key Details

Aspect Status
Issue Website unavailability
Cause Unexpected technical issue
Operations Impact None
Financial Systems Impact None
Regulatory Reference SEBI LODR Regulation 30

The company stated that any material developments regarding the restoration of the website will be communicated to the stock exchange as required under the applicable regulatory framework.

Historical Stock Returns for Beryl Drugs

1 Day5 Days1 Month6 Months1 Year5 Years
+2.03%+0.59%+4.29%-1.64%+5.89%+130.52%

What is the estimated timeline for the full restoration of the website?

Could this technical issue indicate deeper vulnerabilities in Beryl Drugs' IT infrastructure?

How might prolonged website downtime affect customer trust and digital sales channels?

Beryl Drugs board approves shifting of registered office within Indore

1 min read     Updated on 16 Jun 2026, 03:21 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Beryl Drugs Limited's board approved the shifting of its registered office within Indore on June 16, 2026. The office will move from 133, Kanchan Bagh to 29, Neer Nagar, Mayank Water Park Road, Bicholi.

powered bylight_fuzz_icon
43149072

*this image is generated using AI for illustrative purposes only.

beryl drugs Limited has approved the relocation of its registered office within Indore, effective following a board meeting on June 16, 2026. The shift involves moving the corporate address from Ground Floor, 133, Kanchan Bagh, Indore-452001 to 29, Neer Nagar, Mayank Water Park Road, Bicholi, Indore-452016. The decision was taken during the company's 3/2026-2027 board meeting held at the existing registered office.

Board Meeting Details

The meeting of the Board of Directors was convened on Tuesday, June 16, 2026, at 02:00 P.M. and concluded at 03:00 P.M. The primary agenda item was the approval to change the registered office address within the local limits of the same city. Managing Director Sanjay Sethi signed the communication to the Bombay Stock Exchange regarding the outcome.

New Address Details

The company provided the specific coordinates for the new location to ensure compliance with regulatory requirements. The move remains within the same municipal jurisdiction, requiring notification to the exchange but not necessarily a broader shareholder vote typically associated with inter-city shifts.

Detail Information
Old Address Ground Floor, 133, Kanchan Bagh, Indore - 452001 (M.P.)
New Address 29, Neer Nagar, Mayank Water Park Road, Bicholi, Indore - 452016 (M.P.)
Meeting Date June 16, 2026
Meeting Time 02:00 P.M. to 03:00 P.M.

The Bombay Stock Exchange has been requested to update its records with the new registered office details.

Historical Stock Returns for Beryl Drugs

1 Day5 Days1 Month6 Months1 Year5 Years
+2.03%+0.59%+4.29%-1.64%+5.89%+130.52%

What strategic or operational benefits does Beryl Drugs expect to gain from relocating to the Bicholi area?

Will this relocation lead to any changes in the company's operational capacity or workforce expansion?

Are there any cost implications associated with the move that could impact the company's financial performance?

More News on Beryl Drugs

1 Year Returns:+5.89%